Heart surgeons know bypass patients with hypothyroidism face extra risks, but mild cases called subclinical hypothyroidism often fly under the radar pre-op. This hidden thyroid slowdown shows normal hormone levels but high TSH, affecting thousands yearly. 
In the study published in the Cardiovascular Therapeutics, the researchers reviewed 863 adults who had coronary artery bypass grafting from 2010 to 2019 at a major center. They tracked major adverse heart events like death, stroke, heart attack, and repeat fixes, plus surgery problems such as irregular heartbeats, fluid buildup, and infections. 
Big Jump in Heart Events After Surgery
Subclinical hypothyroidism patients hit 20.3% major heart events versus 8.2% in normal cases—a strong split at P=0.001. The four-part event score reached 22% versus 12.9% at P=0.002. Strokes stood out highest at 10.2% against 3% at P=0.013. Deaths, heart attacks, and new artery work showed no gap.
Surgery Complications Pile Up Too
Post-op troubles struck harder too. Atrial fibrillation hit 18.6% versus 9.7% at P=0.043. Pleural effusions soared to 52.6% from 19.2% at under 0.0001. Pericardial effusions reached 20.3% against 7.8% at P=0.03. Any site infections landed at 28.8% versus 16.9% at P=0.032. Only deep chest infections matched in both the groups.
Why Thyroid Checks Matter Pre-Op
Mild thyroid drag slows healing, stirs inflammation, and stresses new grafts through subtle metabolic shifts. TSH screening catches this cheap and easy.
Change Bypass Prep for Safety
Cardiothoracic teams should test TSH routinely and weigh thyroid medications for mild highs. This cuts strokes, rhythms, and fluids without big cost. Patients gain smoother recovery.